Poor Science; Poorly Trained Scientists; Poor Policies: Major Deterrents to the War on Cancer
- Authors
-
-
Leslie C. Costello
School of Dentistry Department of Oncology and Diagnostic Sciences and the Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
-
- Keywords:
- Cancer, NIH policies, training of scientists, excessive molecular biology, holistic physiological/pathophysiological approach.
- Abstract
-
Although the availability of funding has been described as the major limitation on advances in cancer, the progress in the war on cancer has been deterred mainly by poor science, poorly trained scientists, and poor NIH policies. This is the result of NIH policies of its extreme focus on molecular biology (genomics, molecular genetics, molecular biology) identification of the molecular factors and pathways; which are required for the acceptability of treatment and preventive protocols. As such, this has influenced virtually all agencies that provide grants for medical research to adopt the NIH policies. This has impacted the funding of the research as well as the focus of the training of scientists. Directors of NCI Dr. Varmus (also Nobel Prize awardee) and Dr. Zerhouni had addressed this issue; and they rejected the necessity of molecular biology studies and information. NIH should return to the holistic physiological/pathophysiological approach to studies of cancer issues. This would provide the best approach for winning the war on cancer.
- Downloads
-
Download data is not yet available.
- References
-
Zerhouni E. The NIH roadmap. Science 2003; 332: 63-5. https://doi.org/10.1126/science.1091867
Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 2004; 149(6): 76-82.
Costello LC. The effect of contemporary education and training of biomedical scientists on present and future medical research. Acad Med 2009; 84: 459-63. https://doi.org/10.1097/ACM.0b013e31819a7c6b
Perspective: Is NIH funding the "best science by the best scientists"? A critique of the NIH R01 research grant review policies. Acad Med 2010; 85(5): 775-9. https://doi.org/10.1097/ACM.0b013e3181d74256
National Institutes of Health. Enhancing Peer Review at NIH: Overview. Available at: http://enhancing-peer-review.nih.gov/index.html. Accessed January 18, 2010
Office of Extramural Research, National Institutes of Health. Encouraging Early Transition to Research Independence: Modifying the NIH New Investigator Policy to Identify Early Stage Investigators. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-121.html. Accessed January 18, 2010.
Bernard C. An Introduction to the Study of Experimental Medicine. New York, NY: The Macmillan Company 1927.
- Downloads
- Published
- 15-08-2018
- Issue
- Vol. 7 No. 3 (2018)
- Section
- Articles
How to Cite
Similar Articles
- Irene Ruiz, Freddy Fernando Durán, Carmen Sáez, Julián Sanz, Adela Pelayo, Fernando Moreno, Jorge Ruiz, Luis Ortega, Alejandro Pascual, HER2 Expression Discordance between Ductal Carcinoma In situ and Invasive Breast Carcinoma. How to Analyze Oncotype DX , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- Umesh C. Gupta, Subhas C. Gupta, A Guide for Future Therapeutics Based upon the Function of Enzymes and Proteins in Human Pathologic Metabolic Processes , Journal of Cancer Research Updates: Vol. 6 No. 3 (2017)
- Jamison Wijaya, Indrayadi Gunardi, Julvyn Julvyn, Christopher Lim, Benny Nicolas Johannis, Firstine Kelsi Hartanto, Adrianus Rajasa, Rahmi Amtha, Elizabeth Fitriana Sari, Selecting the Appropriate Oral Cancer Cell Line: Characteristic-Based Recommendations from a Systematic Review , Journal of Cancer Research Updates: Vol. 14 (2025)
- Ana-Matea Mikecin, Mira Grdisa, TAT-Mediated Delivery of p27 in Tumor Cell Lines as a Potential Therapeutic Peptide , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Ghazala H. Rizwani, De-Shen Wang, Mansoor Ahmed, Amir Hassan, Zheng-Rong Lai, Affnan Zahid, Najia Mansoor, Huma Sharif, Zhe-Sheng Chen, Zhi Shi, Anticancer Activity of Five Traditionally Used Medicinal Plants' Extracts , Journal of Cancer Research Updates: Vol. 3 No. 2 (2014)
- Jingfang Yao, Mengjie Zhao, Jiangyun Wang, Liuya Wei, Advances in New Targets for Differentiation Therapy of Acute Myeloid Leukemia , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Amy Zhong, Melissa Chang, Theresa Yu, Raymond Gau, Daniel J. Riley, Yumay Chen, Phang-Lang Chen, Aberrant DNA Damage Response and DNA Repair Pathway in High Glucose Conditions , Journal of Cancer Research Updates: Vol. 7 No. 3 (2018)
- Chao Li, Wei Li, Lathika Mohanraj, Qing Cai, Mitchell S. Anscher, Youngman Oh, Multiple Mechanisms for Anti-Fibrotic Functions of Statins on Radiotherapy Induced Fibrosis , Journal of Cancer Research Updates: Vol. 3 No. 1 (2014)
- Riya Jacob, J. Jenkin Winston, Brain Tumor Segmentation using Osprey Optimization Assisted DeepLabV3+ Model , Journal of Cancer Research Updates: Vol. 14 (2025)
- Sandhiya Selvarajan , Melvin George, Suresh Kumar S., Steven Aibor Dkhar, Recent Advances in Cancer Vaccines - An Update , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
You may also start an advanced similarity search for this article.